Global CHC market +2.6% in MAT Q3 2021

The latest update from Nicholas Hall’s CHC database, DB6, shows that in MAT Q3 2021, the store retail CHC market advanced by 2.6%, a continued improvement over results seen throughout the year (vs -0.6% and +1.7% for MAT Q1 and Q2 respectively).

  • Vitamins, Minerals & Supplements (+6.1%) maintains its position as the fastest-growing category, albeit at a slightly slower rate. Stabilising immune-associated segments still contribute to a healthy topline performance as consumers continue to bolster natural defences; this, coupled with improvements in other subcategories (notably a return to growth for probiotics) has helped to keep the largest major category buoyant
  • Lifestyle CHC growth advanced to +5.9%, with eye care — the largest subcategory — returning a mid-single digit increase (+5.4%); this, alongside sustained double-digit increases in sedatives & sleep aids (+13.8%), as well as smaller categories such as emergency hormonal contraception and erectile dysfunction, boosted the topline
  • Gastrointestinals growth improved (+5.2%) with all subcategories once again seeing an upturn over the previous reporting period — a return to some “normalisation of life” (travel, dining out, etc.) has helped the wider category advance
  • Analgesics saw a further improvement overall (+3.6%) boosted by systemics returning to growth (+1.9%) after successive negative results, as well as consistent gains in topical formats (+7.2%)
  • Dermatologicals slowed further to +0.6% (vs +3.9% MAT Q2 21), a trend heavily impacted by the performance of antiseptics & disinfectants — the subcategory now declining by 9.8% following high growth levels seen in the peak of the pandemic
  • Cough, Cold & Allergy remains negative, with sales retracting by 5.3% in the 12 months to end-Sept 21. However, the macro trend continues to improve over the previous reporting periods (-14.5% and -9.7% for MAT Q1 and Q2 respectively) as incidence of typical seasonal pathologies rises vs a low comparator in 2020, with many players reporting improvements in quarterly terms

In terms of geographies:

  • Americas advanced by 2.4% (vs +1.3% MAT Q2 21) – N America now displaying a positive trend with continued improvements in USA & Canada. LatAm markets remain strong, with another double-digit result in Brazil (+12.1%), the most robust of the Top 20 markets
  • Asia held on to mid-level growth (+4.8%) in the reporting period; while the region continues to be impacted by loss of revenue from overseas visitors in key markets Japan (-2.1%) and Australia (-2.9%), steady single-digit increases in China and India helped to maintain the topline
  • Europe’s performance has flattened; Western European markets are improving (-2.0% vs -4.4% MAT Q2 21), impacted by the analgesics growth trend returning to positive, plus a softening decline for CCA over the previous reporting period. CEE markets advanced further, aided by mid-single-digit gains in Poland (+4.8%)

Nicholas Hall commented: Good news! My colleague Kayleigh Griffin-Hooper tells me that the latest DB6 data show that the store retail CHC market continued on a path to recovery in the 12 months to end-September. Broadly speaking, the majority of markets are returning to slightly stronger growth – or softer declines – compared to MAT Q2. Trends remain heavily influenced by the impact of Covid-19 across several healthcare segments – both positively and negatively – resulting in low level advances on a global level.

In three months’ time, when we have sales data for the Internet channel, it will be interesting to see whether this high-growth sector fully balances the softness in store retail sales.

We are pleased to announce that Nicholas Hall’s DB6 MAT Q3 2021 update is now available! Subscribers can access over 150,000 pieces of data, with more than 30,000 records covering 13,000+ brands and 3,000 companies across 63 countries. To find out more, or to set up a free demo, please contact kate.holdcroft@NicholasHall.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s